Covid-19 Update: NYS Residents with T1D and T2D Eligible for Vaccine as of Feb 15
More details are expected and Web sites in the links below will be updated as more information is available

Starting February 15, New York State will allow residents with type 1 and type 2 diabetes to receive the Covid-19 vaccine.  

People with diabetes who are New York State residents will be able to register for a vaccine appointment once the online systems are updated to reflect the new eligibility criteria.  

Vaccine appointments at the NewYork-Presbyterian Hospital/CHONY site at the Armory at 168th St can be scheduled through Connect. At this time, only New York City residents are eligible to be vaccinated at this site. It is not yet clear if or when this will change. Please see VaccineTogetherNY.org or call 646.697.VACC for the most up to date information.

Residents of NYC can locate additional sites here: NYC Vaccination Locations. People residing outside of NYC can locate sites here: New York State Vaccination Locations.  

The Berrie Center cannot schedule vaccine appointments for patients. This must be done by the patient and/or family. In addition, the Berrie Center is not authorized to administer the vaccine. Vaccinations are being offered at sites selected by New York State. 

We are confident that the Covid-19 vaccine is safe for people with diabetes. People with diabetes have participated in the Pfizer/BioNTech and Moderna trials. People who receive the vaccine might experience a mild reaction including a low-grade fever or injection site soreness. However, this is expected, and is not cause for alarm.   

At this point in time, the Covid-19 vaccine is only approved for people over the age of 18 years for the Moderna vaccine, and over the age of 16 years for the Pfizer vaccine. The Berrie Center will notify patients as new guidance becomes available.